CG Oncology, Inc. - CGON

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Aug 14, 2026 SCHEDULE 13G/A Foresite Capital Fund V, L.P. 1.2% 1,079,050 View
Aug 14, 2026 SCHEDULE 13G/A Foresite Capital Management V, LLC 1.2% 1,079,050 View
Aug 14, 2026 SCHEDULE 13G/A Foresite Capital Opportunity Fund V, L.P. 1.0% 857,550 View
Aug 14, 2026 SCHEDULE 13G/A Foresite Capital Opportunity Management V, LLC 1.0% 857,550 View
Aug 14, 2026 SCHEDULE 13G/A Foresite Capital Fund VI LP 2.7% 2,369,574 View
Aug 14, 2026 SCHEDULE 13G/A Foresite Capital Management VI LLC 2.7% 2,369,574 View
Aug 14, 2026 SCHEDULE 13G/A James B. Tananbaum 4.9% 4,306,174 View
Aug 14, 2026 SCHEDULE 13G/A RTW Investments, LP 9.7% 8,514,590 View
Aug 14, 2026 SCHEDULE 13G/A Roderick Wong 9.7% 8,514,590 View
Aug 13, 2026 SCHEDULE 13G/A Wellington Management Group LLP 6.0% 5,324,751 View
Aug 13, 2026 SCHEDULE 13G/A Wellington Group Holdings LLP 6.0% 5,324,751 View
Aug 13, 2026 SCHEDULE 13G/A Wellington Investment Advisors Holdings LLP 6.0% 5,324,751 View
Aug 13, 2026 SCHEDULE 13G/A Wellington Management Company LLP 5.7% 5,324,751 View
Jul 27, 2026 SCHEDULE 13G/A BlackRock, Inc. 6.8% 6,023,696 View
May 15, 2026 SCHEDULE 13G T. Rowe Price Investment Management, Inc. 8.0% 6,720,389 View
May 15, 2026 SCHEDULE 13G RTW Investments, LP 8.3% 6,984,808 View
May 15, 2026 SCHEDULE 13G Roderick Wong 8.3% 6,984,808 View
Mar 26, 2026 SCHEDULE 13G/A The Vanguard Group 0.0% 0 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.